147 related articles for article (PubMed ID: 37409000)
21. Effect of MP-AzeFlu compared to monotherapy on COX-2, PGE
Vicens-Artes S; Roca-Ferrer J; Tubita V; Fuentes M; Alobid I; Valero A; Kopietz F; Nguyen D; Mullol J
Immun Inflamm Dis; 2023 Jan; 11(1):e709. PubMed ID: 36705401
[TBL] [Abstract][Full Text] [Related]
22. A Randomized Comparison of the Pharmacokinetics and Bioavailability of Fluticasone Propionate Delivered via Xhance Exhalation Delivery System Versus Flonase Nasal Spray and Flovent HFA Inhalational Aerosol.
Messina JC; Offman E; Carothers JL; Mahmoud RA
Clin Ther; 2019 Nov; 41(11):2343-2356. PubMed ID: 31732149
[TBL] [Abstract][Full Text] [Related]
23. An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu
Marth K; Renner A; Langmayr G; Pohl W; Nguyen DT; Kuhl HC
Drugs Real World Outcomes; 2024 Jun; 11(2):231-240. PubMed ID: 38351402
[TBL] [Abstract][Full Text] [Related]
24. Correction: A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
Pulm Ther; 2024 Mar; 10(1):143-144. PubMed ID: 38099987
[No Abstract] [Full Text] [Related]
25. Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.
Berger W; Sher E; Gawchik S; Fineman S
Allergy Asthma Proc; 2018 Mar; 39(2):110-116. PubMed ID: 29490769
[TBL] [Abstract][Full Text] [Related]
26. MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis.
van Weissenbruch R; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; Kuhl HC; Pohl W; Scadding GK; Price D; Mullol J
J Asthma Allergy; 2020; 13():633-645. PubMed ID: 33293835
[TBL] [Abstract][Full Text] [Related]
27. Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma.
Price D; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
Clin Mol Allergy; 2020; 18():15. PubMed ID: 32782442
[TBL] [Abstract][Full Text] [Related]
28. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
Klimek L; Mullol J; Hellings P; Gevaert P; Mösges R; Fokkens W
Expert Opin Pharmacother; 2016; 17(5):657-69. PubMed ID: 26800187
[TBL] [Abstract][Full Text] [Related]
29. A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu.
Dollner R; Lorentz Larsen P; Dheyauldeen S; Steinsvåg S
Allergy Rhinol (Providence); 2017 Oct; 8(3):148-156. PubMed ID: 29070272
[TBL] [Abstract][Full Text] [Related]
30. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study.
Klimek L; Price D; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
Int Arch Allergy Immunol; 2020; 181(10):754-764. PubMed ID: 32829329
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care.
De Jong HJI; Voorham J; Scadding GK; Bachert C; Canonica GW; Smith P; Wahn U; Ryan D; Castillo JA; Carter VA; Murray RB; Price DB
World Allergy Organ J; 2020 Dec; 13(12):100490. PubMed ID: 33376573
[TBL] [Abstract][Full Text] [Related]
32. Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study.
Shentu J; Zhou H; Hu X; Wu G; Wu L; Zhu M; Zhai Y; Zheng Y; Liu J
Clin Ther; 2014 Apr; 36(4):579-85. PubMed ID: 24656153
[TBL] [Abstract][Full Text] [Related]
33. Bioequivalence and pharmacokinetic comparison of a single 200-mg dose of meclofenoxate hydrochloride capsule and tablet formulations in healthy Chinese adult male volunteers: a randomized sequence, open-label, two-period crossover study.
Zou JJ; Ji HJ; Wu DW; Yao J; Hu Q; Xiao DW; Wang GJ
Clin Ther; 2008 Sep; 30(9):1651-7. PubMed ID: 18840370
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
Klimek L; Demoly P; Price D
Expert Rev Clin Pharmacol; 2016; 9(5):705-14. PubMed ID: 26839083
[TBL] [Abstract][Full Text] [Related]
35. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
[TBL] [Abstract][Full Text] [Related]
36. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of intranasal olopatadine in the fixed-dose combination GSP301 versus two monotherapy intranasal olopatadine formulations.
Patel P; Salapatek AM; Talluri RS; Tantry SK
Allergy Asthma Proc; 2018 May; 39(3):224-231. PubMed ID: 29669667
[TBL] [Abstract][Full Text] [Related]
38. Single-dose bioequivalence assessment of two formulations of polysaccharide iron complex capsules in healthy adult male Chinese volunteers: A sequence-randomized, double-blind, two-way crossover study.
Zhang YY; Liu JH; Su F; Lui YT; Li JF
Curr Ther Res Clin Exp; 2009 Apr; 70(2):104-15. PubMed ID: 24683222
[TBL] [Abstract][Full Text] [Related]
39. A clinical pharmacokinetic study comparing two azelastine hydrochloride nasal formulations in a single-dose design.
Du D; Targett D; Stolberg E; Canali A
Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):69-75. PubMed ID: 23681835
[TBL] [Abstract][Full Text] [Related]
40. Intranasal Azelastine and Fluticasone as Combination Therapy for Allergic Rhinitis: Systematic Review and Meta-analysis.
Debbaneh PM; Bareiss AK; Wise SK; McCoul ED
Otolaryngol Head Neck Surg; 2019 Sep; 161(3):412-418. PubMed ID: 30961435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
